HASCHKE-BECHER ELISABETH
Department of Laboratory Medicine
Publications
|
Researcher Profile
127 Publications
2023
Journal Articles
Diagnostic Workup of Microcytic Anemia: An Evaluation of Underuse or Misuse of Laboratory Testing in a Hospital Setting Using the AlinIQ System.
Cadamuro, J; Simundic, AM; von Meyer, A; Haschke-Becher, E; Keppel, MH; Oberkofler, H; Felder, TK; Mrazek, C;
Arch Pathol Lab Med. 2023; 147(1): 117-124.
Full papers/articles (Journal)
Paracelsus 10,000:
An observational cohort study about the health status of the population of Salzburg, Austria. Rationale, objectives and study design
Vanessa Frey, Patrick Langthaler, Emanuel Raphaelis, Susanne Ring-Dimitriou, Ludmilla Kedenko, Elmar Aigner, Jennifer Martinz, Isabella Gostner, Arne C. Bathke, Reinhold R. Fartacek, Paul Sungler, Michael Studnicka, Elisabeth Haschke-Becher, Eugen Trinka, Bernhard Iglseder, Bernhard Paulweber
Paracelsus Proceedings of Experimental Medicine. 2023; 2(1): 1-17.
Full papers/articles (Journal)
2022
Journal Articles
Acidification of 24-hour urine in urolithiasis risk testing: An obsolete relic?
Cadamuro, J; Decho, C; Frans, G; Auer, S; von Meyer, A; Kniewallner, KM; Drerup, M; Heinrich, E; Keppel, MH; Mrazek, C; Felder, TK; Oberkofler, H; Haschke-Becher, E; Kipman, U; Salek, T; Vermeersh, P;
Clin Chim Acta. 2022; 532: 1-9.
Full papers/articles (Journal)
Efficiency, efficacy and subjective user satisfaction of alternative laboratory report formats. An investigation on behalf of the Working Group for Postanalytical Phase (WG-POST), of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM).
Cadamuro, J; Winzer, J; Perkhofer, L; von Meyer, A; Bauça, JM; Plekhanova, O; Linko-Parvinen, A; Watine, J; Kniewallner, KM; Keppel, MH; Šálek, T; Mrazek, C; Felder, TK; Oberkofler, H; Haschke-Becher, E; Vermeersch, P; Kristoffersen, AH; Eisl, C;
Clin Chem Lab Med. 2022;
Full papers/articles (Journal)
Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study.
Moser, T; OSullivan, C; Otto, F; Hitzl, W; Pilz, G; Schwenker, K; Mrazek, C; Haschke-Becher, E; Trinka, E; Wipfler, P; Harrer, A;
Ther Adv Neurol Disord. 2022; 15: 17562864221092092
Full papers/articles (Journal)
2021
Journal Articles
Presentation and formatting of laboratory results: a narrative review on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group "postanalytical phase" (WG-POST).
Cadamuro, J; Hillarp, A; Unger, A; von Meyer, A; Bauçà, JM; Plekhanova, O; Linko-Parvinen, A; Watine, J; Leichtle, A; Buchta, C; Haschke-Becher, E; Eisl, C; Winzer, J; Kristoffersen, AH;
Crit Rev Clin Lab Sci. 2021; 58(5):329-353
Full papers/articles (Journal)
Effect of five different pneumatic tube carrier inserts on mechanical sample stress: a multicentre evaluation.
Cadamuro, J; von Meyer, A; Johannis, W; Haschke-Becher, E; Keppel, MH; Streichert, T;
Clin Chem Lab Med. 2021; 59(8):e313-e316
Letters
The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF
Harrer, C; Otto, F; Pilz, G; Haschke-Becher, E; Trinka, E; Hitzl, W; Wipfler, P; Harrer, A
FLUIDS BARRIERS CNS. 2021; 18(1): 40
Full papers/articles (Journal)
Cladribine Alters Immune Cell Surface Molecules for Adhesion and Costimulation: Further Insights to the Mode of Action in Multiple Sclerosis.
Moser, T; Hoepner, L; Schwenker, K; Seiberl, M; Feige, J; Akgün, K; Haschke-Becher, E; Ziemssen, T; Sellner, J;
Cells. 2021; 10(11):
Full papers/articles (Journal)
Pre-Existing Humoral Immunological Memory Is Retained in Patients with Multiple Sclerosis Receiving Cladribine Therapy.
Moser, T; OSullivan, C; Puttinger, C; Feige, J; Pilz, G; Haschke-Becher, E; Cadamuro, J; Oberkofler, H; Hitzl, W; Harrer, A; Kraus, J; Trinka, E; Wipfler, P;
Biomedicines. 2021; 9(11):
Full papers/articles (Journal)
Tetravalent Influenza Vaccine Is Not Associated With Neuroaxonal Damage in Multiple Sclerosis Patients.
Moser, T; Seiberl, M; Feige, J; Bieler, L; Radlberger, RF; OSullivan, C; Pilz, G; Harrer, A; Schwenker, K; Haschke-Becher, E; Machegger, L; Grimm, J; Redlberger-Fritz, M; Buchmann, A; Khalil, M; Kvas, E; Trinka, E; Wipfler, P;
Front Immunol. 2021; 12:718895
Full papers/articles (Journal)
Laboratory Demand Management Strategies-An Overview.
Mrazek, C; Haschke-Becher, E; Felder, TK; Keppel, MH; Oberkofler, H; Cadamuro, J;
Diagnostics (Basel). 2021; 11(7):
Reviews
2020
Journal Articles
Effect of two organizational interventions on the frequency of haemoglobin A1c and erythrocyte sedimentation rate testing.
Cadamuro, J; Mrazek, C; Keppel, MH; Felder, TK; Oberkofler, H; Haschke-Becher, E;
Clin Chem Lab Med. 2020; 59(2):e77-e78
Letters
The clinically effective use of cardiac markers by restructuring laboratory profiles at Cardiology wards.
Keppel, MH; Kolbitsch, T; Hoppe, UC; Auer, S; Felder, TK; Oberkofler, H; Mrazek, C; Haschke-Becher, E; Cadamuro, J;
Clin Chem Lab Med. 2020; 58(9):1565-1571
Full papers/articles (Journal)
Long-term peripheral immune cell profiling reveals further targets of oral cladribine in MS.
Moser, T; Schwenker, K; Seiberl, M; Feige, J; Akgün, K; Haschke-Becher, E; Ziemssen, T; Sellner, J;
Ann Clin Transl Neurol. 2020; 7(11):2199-2212
Full papers/articles (Journal)
Errors within the total laboratory testing process, from test selection to medical decision-making - A review of causes, consequences, surveillance and solutions.
Mrazek, C; Lippi, G; Keppel, MH; Felder, TK; Oberkofler, H; Haschke-Becher, E; Cadamuro, J;
Biochem Med (Zagreb). 2020; 30(2): 020502
Reviews
Inappropriate use of laboratory tests: How availability triggers demand - Examples across Europe.
Mrazek, C; Simundic, AM; Salinas, M; von Meyer, A; Cornes, M; Miquel Bauçà, J; Nybo, M; Lippi, G; Haschke-Becher, E; Keppel, MH; Oberkofler, H; Felder, TK; Cadamuro, J;
Clin Chim Acta. 2020; 505: 100-107.
Full papers/articles (Journal)
Reducing the probability of falsely elevated HbA1c results in diabetic patients by applying automated and educative HbA1c re-testing intervals.
Mrazek, C; Stechemesser, L; Haschke-Becher, E; Hölzl, B; Paulweber, B; Keppel, MH; Simundic, AM; Oberkofler, H; Felder, TK; Cadamuro, J;
Clin Biochem. 2020; 80: 14-18.
Full papers/articles (Journal)
Influence of dabigatran on pro-inflammatory cytokines, growth factors and chemokines - Slowing the vicious circle of coagulation and inflammation.
Paar, V; Jirak, P; Gruber, S; Prodinger, C; Cadamuro, J; Wernly, B; Motloch, LJ; Haschke-Becher, E; Hoppe, UC; Lichtenauer, M;
Life Sci. 2020; 262:118474
Full papers/articles (Journal)
Chemokine CXCL13 in serum, CSF and blood-CSF barrier function: evidence of compartment restriction.
Pilz, G; Sakic, I; Wipfler, P; Kraus, J; Haschke-Becher, E; Hitzl, W; Trinka, E; Harrer, A;
Fluids Barriers CNS. 2020; 17(1): 7
Full papers/articles (Journal)
Beyond LNB: Real life data on occurrence and extent of CSF CXCL13 in neuroinflammatory diseases.
Pilz, G; Steger, R; Wipfler, P; Otto, F; Afazel, S; Haschke-Becher, E; Trinka, E; Harrer, A;
J Neuroimmunol. 2020; 338:577087
Full papers/articles (Journal)
Conference papers, proceedings, abstracts
Genotypes and phenotypes in 6p25 deletion syndrome
Bader, I; Reindl, I; Sander, G; Kronberger, G; Pleyers, A; Mayr, H; Koch, J; Atzwanger, J; Frenzel, C; Haschke-Becher, E; Kotzot, D; Sperl, W
EUR J HUM GENET. 2020; 28(SUPPL 1): 921-922.
Abstracts (Journal)
2019
Journal Articles
Managing inappropriate utilization of laboratory resources.
Cadamuro, J; Ibarz, M; Cornes, M; Nybo, M; Haschke-Becher, E; von Meyer, A; Lippi, G; Simundic, AM;
Diagnosis (Berl). 2019; 6(1):5-13
Full papers/articles (Journal)
Heparin and citrate additive carryover during blood collection.
Keppel, MH; Auer, S; Lippi, G; von Meyer, A; Cornes, M; Felder, TK; Oberkofler, H; Mrazek, C; Haschke-Becher, E; Cadamuro, J;
Clin Chem Lab Med. 2019; 57(12): 1888-1896.
Full papers/articles (Journal)
The endogenous cardiotonic steroid Marinobufagenin and decline in estimated glomerular filtration rate at follow-up in patients with arterial hypertension.
Keppel, MH; Piecha, G; März, W; Cadamuro, J; Auer, S; Felder, TK; Mrazek, C; Oberkofler, H; Trummer, C; Grübler, MR; Schwetz, V; Verheyen, N; Pandis, M; Borzan, V; Haschke-Becher, E; Tomaschitz, A; Pilz, S;
PLoS One. 2019; 14(2): e0212973
Full papers/articles (Journal)
Development and Characterization of the Neuroregenerative Xanthohumol C/Hydroxypropyl-β-cyclodextrin Complex Suitable for Parenteral Administration.
Kirchinger, M; Bieler, L; Tevini, J; Vogl, M; Haschke-Becher, E; Felder, TK; Couillard-Després, S; Riepl, H; Urmann, C;
Planta Med. 2019; 85(16):1233-1241
Full papers/articles (Journal)
Cerebrospinal fluid CXLC13 indicates disease course in neuroinfection: an observational study.
Pilz, G; Wipfler, P; Otto, F; Hitzl, W; Afazel, S; Haschke-Becher, E; Trinka, E; Harrer, A;
J Neuroinflammation. 2019; 16(1): 13
Full papers/articles (Journal)
Conference papers, proceedings, abstracts
A risk-reducing algorithm to prevent HbA1c overutilization
Mrazek, C; Stechemesser, L; Haschke-Becher, E; Holzl, B; Paulweber, B; Keppel, M; Oberkofler, H; Felder, T; Cadamuro, J
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5): S484-S484.
Abstracts (Journal)
2018
Journal Articles
Late age onset of amyotrophic lateral sclerosis is often not considered in elderly people.
Broussalis, E; Grinzinger, S; Kunz, AB; Killer-Oberpfalzer, M; Haschke-Becher, E; Hartung, HP; Kraus, J;
Acta Neurol Scand. 2018; 137(3):329-334
Full papers/articles (Journal)
How do we use the data from pre-analytical quality indicators and how should we?
Cadamuro, J; Gaksch, M; Mrazek, C; Haschke-Becher, E; Plebani, M;
Journal of Laboratory and Precision Medicine. 2018; 4(3): 1-9.
Full papers/articles (Journal)
Are laboratory tests always needed? Frequency and causes of laboratory overuse in a hospital setting.
Cadamuro, J; Gaksch, M; Wiedemann, H; Lippi, G; von Meyer, A; Pertersmann, A; Auer, S; Mrazek, C; Kipman, U; Felder, TK; Oberkofler, H; Haschke-Becher, E;
Clin Biochem. 2018; 54: 85-91.
Full papers/articles (Journal)
Influence of centrifugation conditions on the results of 77 routine clinical chemistry analytes using standard vacuum blood collection tubes and the new BD-Barricor tubes.
Cadamuro, J; Mrazek, C; Leichtle, AB; Kipman, U; Felder, TK; Wiedemann, H; Oberkofler, H; Fiedler, GM; Haschke-Becher, E;
Biochem Med (Zagreb). 2018; 28(1): 010704
Full papers/articles (Journal)
Dynamic reference intervals for coagulation parameters from infancy to adolescence.
Weidhofer, C; Meyer, E; Ristl, R; Wiedemann, H; Cadamuro, J; Kipman, U; Zierk, J; Male, C; Quehenberger, P; Haschke-Becher, E; Einwallner, E;
Clin Chim Acta. 2018; 482: 124-135.
Full papers/articles (Journal)
2017
Journal Articles
The Human NADPH Oxidase, Nox4, Regulates Cytoskeletal Organization in Two Cancer Cell Lines, HepG2 and SH-SY5Y.
Auer, S; Rinnerthaler, M; Bischof, J; Streubel, MK; Breitenbach-Koller, H; Geisberger, R; Aigner, E; Cadamuro, J; Richter, K; Sopjani, M; Haschke-Becher, E; Felder, TK; Breitenbach, M;
Front Oncol. 2017; 7: 111
Full papers/articles (Journal)
Low Protein Formula: Consequences of Quantitative Effects of Pre-analytical Factors on Amino Acid Concentrations in Plasma of Healthy Infants.
Bachmann, C; Kainz, A; Haschke-Becher, E;
JIMD Rep. 2017; 32:59-67
Full papers/articles (Journal)
To report or not to report: a proposal on how to deal with altered test results in hemolytic samples.
Cadamuro, J; Mrazek, C; Haschke-Becher, E; Sandberg, S;
Clin Chem Lab Med. 2017; 55(8): 1109-1111.
Editorials
Effectiveness of a Laboratory Gate-Keeping Strategy to Overcome Inappropriate Test Utilization for the Diagnosis of Heparin-Induced Thrombocytopenia.
Cadamuro, J; Mrazek, C; Wiedemann, H; Felder, TK; Oberkofler, H; Haschke-Becher, E; Lippi, G;
Semin Thromb Hemost. 2017; 43(6): 645-648.
Letters
What´s floating on my plasma?
Cadamuro, J; Wiedemann, H; Felder, TK; Mrazek, C; Kipman, U; Hannes, O; Haschke-Becher, E
Biochem Med (Zagreb). 2017; 27(2):430-433
Case Reports
Specific circulating phospholipids, acylcarnitines, amino acids and biogenic amines are aerobic exercise markers.
Felder, TK; Ring-Dimitriou, S; Auer, S; Soyal, SM; Kedenko, L; Rinnerthaler, M; Cadamuro, J; Haschke-Becher, E; Aigner, E; Paulweber, B; Patsch, W;
J Sci Med Sport. 2017; 20(7):-705
Full papers/articles (Journal)
Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver.
Feldman, A; Eder, SK; Felder, TK; Kedenko, L; Paulweber, B; Stadlmayr, A; Huber-Schönauer, U; Niederseer, D; Stickel, F; Auer, S; Haschke-Becher, E; Patsch, W; Datz, C; Aigner, E;
Am J Gastroenterol. 2017; 112(1):102-110
Full papers/articles (Journal)
From natalizumab to fingolimod in eight weeks - Immunological, clinical, and radiological data in quest of the optimal switch.
Harrer, A; Pilz, G; Oppermann, K; Sageder, M; Afazel, S; Haschke-Becher, E; Rispens, T; de Vries, A; McCoy, M; Stevanovic, V; Hitzl, W; Trinka, E; Kraus, J; Sellner, J; Wipfler, P;
Clin Immunol. 2017; 176: 87-93.
Full papers/articles (Journal)
The relationship between vacuum and hemolysis during catheter blood collection: a retrospective analysis of six large cohorts.
Mrazek, C; Simundic, AM; Wiedemann, H; Krahmer, F; Felder, TK; Kipman, U; Hoppe, U; Haschke-Becher, E; Cadamuro, J;
Clin Chem Lab Med. 2017; 55(8):1129-1134
Full papers/articles (Journal)
Coronary angiography as a rare cause for incomplete anterior spinal artery syndrome.
Pilz, G; Wipfler, P; Schwarte, O; Golaszewski, S; McCoy, M; Haschke-Becher, E; Hartung, HP; Kraus, J;
J Neurol. 2017; 264(4): 799-801.
Letters
Multibiomarker analysis in patients with acute myocardial infarction.
Schernthaner, C; Lichtenauer, M; Wernly, B; Paar, V; Pistulli, R; Rohm, I; Jung, C; Figulla, HR; Yilmaz, A; Cadamuro, J; Haschke-Becher, E; Pernow, J; Schulze, PC; Hoppe, UC; Kretzschmar, D;
Eur J Clin Invest. 2017; 47(9): 638-648.
Full papers/articles (Journal)
Elevated plasma levels of interleukin-16 in patients with acute myocardial infarction.
Schernthaner, C; Paar, V; Wernly, B; Pistulli, R; Rohm, I; Jung, C; Figulla, HR; Yilmaz, A; Cadamuro, J; Haschke-Becher, E; Schulze, PC; Hoppe, UC; Lichtenauer, M; Kretzschmar, D;
Medicine (Baltimore). 2017; 96(44): e8396
Full papers/articles (Journal)
Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism.
Stechemesser, L; Eder, SK; Wagner, A; Patsch, W; Feldman, A; Strasser, M; Auer, S; Niederseer, D; Huber-Schönauer, U; Paulweber, B; Zandanell, S; Ruhaltinger, S; Weghuber, D; Haschke-Becher, E; Grabmer, C; Rohde, E; Datz, C; Felder, TK; Aigner, E;
Mol Metab. 2017; 6(1):38-47
Full papers/articles (Journal)
Hemeoxygenase-1 as a Novel Driver in Ritonavir-Induced Insulin Resistance in HIV-1-Infected Patients.
Taylor, N; Kremser, I; Auer, S; Hoermann, G; Greil, R; Haschke-Becher, E; Esterbauer, H; Kenner, L; Oberkofler, H;
J Acquir Immune Defic Syndr. 2017; 75(1):e13-e20
Full papers/articles (Journal)
Conference papers, proceedings, abstracts
The immune receptor expression pattern in peripheral-blood associated with JCV seropositivity in patients with multiple sclerosis is not affected by natalizumab
Harrer, A; Frommrich, M; Moser, T; Afazel, S; Haschke-Becher, E; Wipfler, P; Sellner, J
MULT SCLER J. 2017; 23: 337-338.
Abstracts (Journal)
2016
Journal Articles
Reply to: Cadamuro et al. In-vitro hemolysis and its financial impact using different blood collection systems
Cadamuro, J; Fiedler, GM; Mrazek, C; Felder, TK; Oberkofler, H; Kipman, U; Haschke-Becher, E; Wiedemann, H
LABORATORIUMSMEDIZIN. 2016; 40(1): 59-61.
Author reply
In-vitro hemolysis and its financial impact using different blood collection systems
Cadamuro, J; Fiedler, GM; Mrazek, C; Felder, TK; Oberkofler, H; Kipman, U; Haschke-Becher, E; Wiedemann, H
LABORATORIUMSMEDIZIN. 2016; 40(1): 49-55.
Full papers/articles (Journal)
Hemolysis rates in blood samples: differences between blood collected by clinicians and nurses and the effect of phlebotomy training.
Cadamuro, J; von Meyer, A; Wiedemann, H; Felder, TK; Moser, F; Kipman, U; Haschke-Becher, E; Mrazek, C; Simundic, AM;
Clin Chem Lab Med. 2016; 54(12): 1987-1992.
Full papers/articles (Journal)
Reference values of amino acids and of common clinical chemistry in plasma of healthy infants aged 1 and 4 months
Haschke-Becher, E; Kainz, A; Bachmann, C
J INHERIT METAB DIS. 2016; 39(1): 25-37.
Full papers/articles (Journal)
Conference papers, proceedings, abstracts
SPECIFIC CIRCULATING PHOSPHOLIPIDS, ACYLCARNITINES, AMINO ACIDS AND BIOGENIC AMINES ARE AEROBIC EXERCISE MARKERS
Felder, T; Ring-Dimitriou, S; Auer, S; Soyal, S; Kedenko, L; Rinnerthaler, M; Cadamuro, J; Haschke-Becher, E; Aigner, E; Paulweber, B; Patsch, W
ATHEROSCLEROSIS. 2016; 252: E121-E121.
Abstracts (Journal)
2015
Journal Articles
Relevance of EDTA carryover during blood collection.
Cadamuro, J; Felder, TK; Oberkofler, H; Mrazek, C; Wiedemann, H; Haschke-Becher, E;
Clin Chem Lab Med. 2015; 53(8):1271-1278
Full papers/articles (Journal)
The economic burden of hemolysis.
Cadamuro, J; Wiedemann, H; Mrazek, C; Felder, TK; Oberkofler, H; Fiedler, GM; Haschke-Becher, E;
Clin Chem Lab Med. 2015; 53(11): e285-e288.
Letters
High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis.
Harrer, A; Pilz, G; Wipfler, P; Oppermann, K; Sellner, J; Hitzl, W; Haschke-Becher, E; Afazel, S; Rispens, T; van der Kleij, D; Trinka, E; Kraus, J;
Clin Exp Immunol. 2015; 180(3):383-392
Full papers/articles (Journal)
Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod.
Harrer, A; Wipfler, P; Pilz, G; Oppermann, K; Haschke-Becher, E; Afazel, S; Kraus, J; Trinka, E; Sellner, J;
Int J Mol Sci. 2015; 16(9): 21832-21845.
Full papers/articles (Journal)
Haemostatic profile of reconstituted blood in a proposed 1:1:1 ratio of packed red blood cells, platelet concentrate and four different plasma preparations.
Ponschab, M; Schöchl, H; Gabriel, C; Süssner, S; Cadamuro, J; Haschke-Becher, E; Gratz, J; Zipperle, J; Redl, H; Schlimp, CJ;
Anaesthesia. 2015; 70(5): 528-536.
Full papers/articles (Journal)
Conference papers, proceedings, abstracts
SOLUBLE P-SELECTIN PREDICTS CARDIOVASCULAR EVENTS IN END STAGE RENAL DISEASE
Sailer, T; Haschke-Becher, E; Pabinger, I; Ay, C; Oberbauer, R
NEPHROL DIAL TRANSPL. 2015; 30:
Abstracts (Journal)
2014
Journal Articles
Does docosahexaenoic acid (DHA) status in pregnancy have any impact on postnatal growth? Six-year follow-up of a prospective randomized double-blind monocenter study on low-dose DHA supplements.
Bergmann, RL; Bergmann, KE; Richter, R; Haschke-Becher, E; Henrich, W; Dudenhausen, JW
J Perinat Med. 2014; 40(6):677-684
Full papers/articles (Journal)
TaqManR proximity ligation technology for the detection of heterodimeric adhesion receptors on lymphocytes.
Gehwolf, R; Band, E; Trost, A; Iglseder, B; Trinka, E; Haschke-Becher, E; Kraus, J; Harrer, A;
J Immunol Methods. 2014; 404:81-86
Full papers/articles (Journal)
A routine-qualified flow cytometric method for the identification of multiple sclerosis patients with reduced therapy efficiency under natalizumab
Oppermann, K; Harrer, A; Pilz, G; Wipfler, P; Afazel, S; Haschke-Becher, E; Sellner, J; Deisenhammer, F; Trinka, E; Kraus, J
LABORATORIUMSMEDIZIN. 2014; 38(1): 17-23.
Full papers/articles (Journal)
CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations.
Province, MA; Goetz, MP; Brauch, H; Flockhart, DA; Hebert, JM; Whaley, R; Suman, VJ; Schroth, W; Winter, S; Zembutsu, H; Mushiroda, T; Newman, WG; Lee, MT; Ambrosone, CB; Beckmann, MW; Choi, JY; Dieudonné, AS; Fasching, PA; Ferraldeschi, R; Gong, L; Haschke-Becher, E; Howell, A; Jordan, LB; Hamann, U; Kiyotani, K; Krippl, P; Lambrechts, D; Latif, A; Langsenlehner, U; Lorizio, W; Neven, P; Nguyen, AT; Park, BW; Purdie, CA; Quinlan, P; Renner, W; Schmidt, M; Schwab, M; Shin, JG; Stingl, JC; Wegman, P; Wingren, S; Wu, AH; Ziv, E; Zirpoli, G; Thompson, AM; Jordan, VC; Nakamura, Y; Altman, RB; Ames, MM; Weinshilboum, RM; Eichelbaum, M; Ingle, JN; Klein, TE;
Clin Pharmacol Ther. 2014; 95(2):216-227
Full papers/articles (Journal)
Performance characteristics of the COBAS Ampliprep/COBAS TaqMan v2.0 and the Abbott RealTime hepatitis C assays - implications for response-guided therapy in genotype 1 infections.
Taylor, N; Haschke-Becher, E; Greil, R; Strasser, M; Oberkofler, H;
Antivir Ther. 2014; 19(5): 449-454.
Full papers/articles (Journal)
Natalizumab saturation: biomarker for individual treatment holiday after natalizumab withdrawal?
Wipfler, P; Harrer, A; Pilz, G; Oppermann, K; Afazel, S; Haschke-Becher, E; Sellner, J; Trinka, E; Kraus, J;
Acta Neurol Scand. 2014; 129(3):e12-e15
Full papers/articles (Journal)
2013
Journal Articles
Feeding patterns during the first 2 years and health outcome.
Haschke, F; Haiden, N; Detzel, P; Yarnoff, B; Allaire, B; Haschke-Becher, E
Ann Nutr Metab. 2013; 62 Suppl 3:16-25
Full papers/articles (Journal)
Evaluation of growth and early infant feeding: a challenge for scientists, industry and regulatory bodies.
Haschke, F; Steenhout, P; Grathwohl, D; Haschke-Becher, E
World Rev Nutr Diet. 2013; 106:33-38
Reviews
A randomized trial of genotype-guided dosing of warfarin.
Pirmohamed, M; Burnside, G; Eriksson, N; Jorgensen, AL; Toh, CH; Nicholson, T; Kesteven, P; Christersson, C; Wahlström, B; Stafberg, C; Zhang, JE; Leathart, JB; Kohnke, H; Maitland-van der Zee, AH; Williamson, PR; Daly, AK; Avery, P; Kamali, F; Wadelius, M;
N Engl J Med. 2013; 369(24): 2294-2303.
Full papers/articles (Journal)
– contribution as Studygroup-member
Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis.
Sellner, J; Koczi, W; Harrer, A; Oppermann, K; Obregon-Castrillo, E; Pilz, G; Wipfler, P; Afazel, S; Haschke-Becher, E; Trinka, E; Kraus, J;
Clin Exp Immunol. 2013; 173(3):381-389
Full papers/articles (Journal)
A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon.
Verhoef, TI; Ragia, G; de Boer, A; Barallon, R; Kolovou, G; Kolovou, V; Konstantinides, S; Le Cessie, S; Maltezos, E; van der Meer, FJ; Redekop, WK; Remkes, M; Rosendaal, FR; van Schie, RM; Tavridou, A; Tziakas, D; Wadelius, M; Manolopoulos, VG; Maitland-van der Zee, AH;
N Engl J Med. 2013; 369(24): 2304-2312.
Full papers/articles (Journal)
– contribution as Studygroup-member
Cost-effectiveness of pharmacogenetic-guided dosing of phenprocoumon in atrial fibrillation.
Verhoef, TI; Redekop, WK; Veenstra, DL; Thariani, R; Beltman, PA; van Schie, RM; de Boer, A; Maitland-van der Zee, AH;
Pharmacogenomics. 2013; 14(8): 869-883.
Full papers/articles (Journal)
– contribution as Studygroup-member
Conference papers, proceedings, abstracts
Shift in the CD4+/CD8+ratio of cerebrospinal fluid T cells independent from free or cell-bound natalizumab
Harrer, A; Oppermann, K; Pizl, G; Wipfler, P; Sellner, J; Hitzl, W; Haschke-Becher, E; Afazel, S; Rispens, T; van der Kleij, D; Trinka, E; Kraus, J
MULT SCLER J. 2013; 19(11): 451-452.
Abstracts (Journal)
Flow-cytometry and the detection of natalizumab-neutralizing antibodies in multiple sclerosis
Oppermann, K; Harrer, A; Pilz, G; Wipfler, P; Holl, B; Deisenhammer, F; Afazel, S; Haschke-Becher, E; Trinka, E; Kraus, J
MULT SCLER J. 2013; 19(11): 500-501.
Abstracts (Journal)
Book chapters
Pharmakogenetik
Haschke-Becher, E
In: Dörner, K. (Hrsg.) editors(s). Taschenlehrbuch Klinische Chemie und Hämatologie. (20.5): Thieme; p. 572-574.
2012
Journal Articles
Isolated leptomeningeal infiltration of a primary CNS B-cell lymphoma diagnosed by flow cytometry and confirmed by necropsy.
Broussalis, E; Hutterer, M; Oppermann, K; Wipfler, P; Pilz, G; Harrer, A; Haschke-Becher, E; Golaszewski, S; Schönauer, U; Weis, S; Killer-Oberpfalzer, M; Mc Coy, M; Trinka, E; Kraus, J;
Acta Neurol Scand. 2012; 126(3):e11-e16
Case Reports
Flow cytometry and drug monitoring of natalizumab saturation of immune cells in multiple sclerosis
Harrer, A; Oppermann, K; Pilz, G; Wipfler, P; Afazel, S; Haschke-Becher, L; Trinka, E; Kraus, J
LABORATORIUMSMEDIZIN. 2012; 36(6): 377-382.
Full papers/articles (Journal)
Lymphocyte subsets show different response patterns to in vivo bound natalizumab--a flow cytometric study on patients with multiple sclerosis.
Harrer, A; Pilz, G; Einhaeupl, M; Oppermann, K; Hitzl, W; Wipfler, P; Sellner, J; Golaszewski, S; Afazel, S; Haschke-Becher, E; Trinka, E; Kraus, J;
PLoS One. 2012; 7(2):e31784
Full papers/articles (Journal)
Impact of CYP2D6 polymorphism on tamoxifen therapy: where are we?
Huber-Wechselberger, AE; Niedetzky, P; Aigner, I; Haschke-Becher, E;
Wien Med Wochenschr. 2012; 162(11-12):252-261
Reviews
Molecular evidence of transient therapeutic effectiveness of natalizumab despite high-titre neutralizing antibodies.
Pilz, G; Harrer, A; Oppermann, K; Wipfler, P; Golaszewski, S; Afazel, S; Haschke-Becher, E; Trinka, E; Kraus, J;
Mult Scler. 2012; 18(4):506-509
Full papers/articles (Journal)
An evaluation of gene-gene interaction between the CYP2C9 and VKORC1 genotypes affecting the anticoagulant effect of phenprocoumon and acenocoumarol.
van Schie, RM; Babajeff, AM; Schalekamp, T; Wessels, JA; le Cessie, S; de Boer, A; van der Meer, FJ; van Meegen, E; Verhoef, TI; Rosendaal, FR; Maitland-van der Zee, AH;
J Thromb Haemost. 2012; 10(5): 767-772.
Full papers/articles (Journal)
– contribution as Studygroup-member
Long-term anticoagulant effects of the CYP2C9 and VKORC1 genotypes in acenocoumarol users.
Verhoef, TI; Redekop, WK; Buikema, MM; Schalekamp, T; Van Der Meer, FJ; Le Cessie, S; Wessels, JA; Van Schie, RM; De Boer, A; Teichert, M; Visser, LE; Maitland-Van Der Zee, AH;
J Thromb Haemost. 2012; 10(4): 606-614.
Full papers/articles (Journal)
– contribution as Studygroup-member
Long-term anticoagulant effects of CYP2C9 and VKORC1 genotypes in phenprocoumon users.
Verhoef, TI; Redekop, WK; Hegazy, H; de Boer, A; Maitland-van der Zee, AH;
J Thromb Haemost. 2012; 10(12): 2610-2612.
Letters
– contribution as Studygroup-member
Cost-effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs.
Verhoef, TI; Redekop, WK; van Schie, RM; Bayat, S; Daly, AK; Geitona, M; Haschke-Becher, E; Hughes, DA; Kamali, F; Levin, LÅ; Manolopoulos, VG; Pirmohamed, M; Siebert, U; Stingl, JC; Wadelius, M; de Boer, A; Maitland-van der Zee, AH;
Pharmacogenomics. 2012; 13(12): 1405-1417.
Reviews
Conference papers, proceedings, abstracts
Natalizumab Treatment Effects Sustained Decrease in Serum Levels of Fibronectin and Soluble Adhesion Molecules sVCAM-1 and sICAM-3
Kraus, J; Oppermann, K; Pilz, G; Wipfler, P; Afazel, S; Haschke-Becher, E; Trinka, E; Harrer, A
NEUROLOGY. 2012; 78:
Abstracts (Journal)
Serum Levels of Soluble Adhesion Molecules Remain Stable during Short- and Long-Term Interferon-beta-1b Treatment
Kraus, J; Zaunrieth, R; Obregon-Castrillo, E; Oppermann, K; Pilz, G; Wipfler, P; Afazel, S; Haschke-Becher, E; Golaszewski, S; Hitzl, W; Trinka, E; Harrer, A
NEUROLOGY. 2012; 78:
Abstracts (Journal)
2011
Journal Articles
A proposal for an individualized pharmacogenetics-based warfarin initiation dose regimen for patients commencing anticoagulation therapy.
Avery, PJ; Jorgensen, A; Hamberg, AK; Wadelius, M; Pirmohamed, M; Kamali, F;
Clin Pharmacol Ther. 2011; 90(5): 701-706.
Full papers/articles (Journal)
– contribution as Studygroup-member
The case: hemolysis and acute renal failure. Babesiosis.
Blum, S; Gattringer, R; Haschke, E; Walochnik, J; Tschurtschenthaler, G; Lang, F; Oberbauer, R;
Kidney Int. 2011; 80(6): 681-683.
Editorials
Natalizumab therapy decreases surface expression of both VLA-heterodimer subunits on peripheral blood mononuclear cells.
Harrer, A; Wipfler, P; Einhaeupl, M; Pilz, G; Oppermann, K; Hitzl, W; Afazel, S; Haschke-Becher, E; Strasser, P; Trinka, E; Kraus, J;
J Neuroimmunol. 2011; 234(1-2):148-154
Full papers/articles (Journal)
The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories.
Kohlmann, A; Klein, HU; Weissmann, S; Bresolin, S; Chaplin, T; Cuppens, H; Haschke-Becher, E; Garicochea, B; Grossmann, V; Hanczaruk, B; Hebestreit, K; Gabriel, C; Iacobucci, I; Jansen, JH; te Kronnie, G; van de Locht, L; Martinelli, G; McGowan, K; Schweiger, MR; Timmermann, B; Vandenberghe, P; Young, BD; Dugas, M; Haferlach, T;
Leukemia. 2011; 25(12): 1840-1848.
Full papers/articles (Journal)
Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer.
Parmar, S; Stingl, JC; Huber-Wechselberger, A; Kainz, A; Renner, W; Langsenlehner, U; Krippl, P; Brockmöller, J; Haschke-Becher, E;
Breast Cancer Res. 2011; 13(3): R57
Full papers/articles (Journal)
Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data.
van Schie, RM; Wessels, JA; le Cessie, S; de Boer, A; Schalekamp, T; van der Meer, FJ; Verhoef, TI; van Meegen, E; Rosendaal, FR; Maitland-van der Zee, AH;
Eur Heart J. 2011; 32(15): 1909-1917.
Full papers/articles (Journal)
– contribution as Studygroup-member
Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatment.
Wipfler, P; Oppermann, K; Pilz, G; Afazel, S; Haschke-Becher, E; Harrer, A; Huemer, M; Kunz, A; Golaszewski, S; Staffen, W; Ladurner, G; Kraus, J;
Mult Scler. 2011; 17(1):16-23
Full papers/articles (Journal)
Conference papers, proceedings, abstracts
Natalizumab binding to peripheral blood mononuclear cells analysed by flow cytometry can be used for monitoring treatment response in patients with multiple sclerosis
Harrer, A; Pilz, G; Einhaeupl, M; Oppermann, K; Wipfler, P; Hitzl, W; Afazel, S; Haschke-Becher, E; Trinka, E; Kraus, J
J NEUROL. 2011; 258: 13-14.
Abstracts (Journal)
A NOVEL MARKER PANEL FOR BRAIN TUMOURS?
Jaksch, H; Strasser, P; Krenn, Y; Golaszewski, S; Kleindienst, W; Hutterer, M; Haschke-Becher, E; Weis, S; Trinka, E; Eckl, P; Bresgen, N
EUR J NEUROL. 2011; 18: 603-603.
Abstracts (Journal)
Anti-Inflammatory Effects of Copaxone on the Level of Adhesion Molecule Expression Patterns during Short- and Long-Term Treatment
Kraus, J; Oppermann, K; Harrer, A; Koczi, W; Duerr, EM; Wipfler, P; Pilz, G; Hitzl, W; Afazel, S; Haschke-Becher, E; Trinka, E
NEUROLOGY. 2011; 76(9): A384-A384.
Abstracts (Journal)
Flow Cytometry of Natalizumab Binding to Immune Cells and Its Potential Use for Monitoring Disease Activity and Treatment Response in Patients with Multiple Sclerosis
Kraus, J; Pilz, G; Einhaeupl, M; Oppermann, K; Wipfler, P; Hitzl, W; Afazel, S; Haschke-Becher, E; Trinka, E; Harrer, A
NEUROLOGY. 2011; 76(9): A135-A136.
Abstracts (Journal)
Copaxone treatment shows anti-inflammatory effects on the level of adhesion molecule expression on peripheral blood mononuclear cells during short- and long-term therapy
Oppermann, K; Harrer, A; Koczi, W; Duerr, E; Wipfler, P; Pilz, G; Hitzl, W; Afazel, S; Haschke-Becher, E; Trinka, E; Kraus, J
J NEUROL. 2011; 258: 206-206.
Abstracts (Journal)
USEFULNES OF URINARY BIOMARKER NGAL IN THE MANAGEMENT OF RENAL REPLACEMENT THERAPY (RRT, HEMOFILTRATION)
Stanger, O; Aigner, I; Mitterwallner, S; Haschke-Becher, E
CLIN CHEM LAB MED. 2011; 49: S362-S362.
Abstracts (Journal)
2010
Journal Articles
First detection of the Anaplasma phagocytophilum groEL-A genotype in man.
Haschke-Becher, E; Bernauer, R; Walleczek, AM; Apfalter, P; Afazel-Saeedi, S; Kraus, J; Ladurner, G; Strasser, P;
J INFECTION. 2010; 60(4): 300-305.
Case Reports
Impact of CYP2C8 and 2C9 polymorphisms on coronary artery disease and myocardial infarction in the LURIC cohort.
Haschke-Becher, E; Kirchheiner, J; Trummer, O; Grünbacher, G; Kainz, A; Boehm, BO; März, W; Renner, W;
Pharmacogenomics. 2010; 11(10): 1359-1365.
Full papers/articles (Journal)
Impact of CYP2D6*4 genotype on progression free survival in tamoxifen breast cancer treatment.
Stingl, JC; Parmar, S; Huber-Wechselberger, A; Kainz, A; Renner, W; Seeringer, A; Brockmöller, J; Langsenlehner, U; Krippl, P; Haschke-Becher, E;
Curr Med Res Opin. 2010; 26(11):2535-2542
Full papers/articles (Journal)
Novel mutation at codon 110 of the human APOE gene: impact on genotyping with fluorescent hybridization probes
Strasser, P; Iglseder, B; Ladurner, G; Haschke-Becher, E
CLIN CHEM LAB MED. 2010; 48(12): 1835-1836.
Letters
A systematic review of cost-effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives.
Verhoef, TI; Redekop, WK; Darba, J; Geitona, M; Hughes, DA; Siebert, U; de Boer, A; Maitland-van der Zee, AH; Barallon, R; Briz, M; Daly, A; Haschke-Becher, E; Kamali, F; Kirchheiner, J; Manolopoulos, VG; Pirmohamed, M; Rosendaal, FR; van Schie, RM; Wadelius, M;
Pharmacogenomics. 2010; 11(7): 989-1002.
Reviews
Conference papers, proceedings, abstracts
Continuous Down-Regulation of VLA-4 and Accumulation of Natalizumab at the VLA-4 Receptor: Potential Molecular Basis of Enhanced Treatment Efficacy and Occurrence of Opportunistic Infections
Kraus, J; Oppermann, K; Wipfler, P; Pilz, G; Harrer, A; Afazel, S; Haschke-Becher, E; Kunz, AB; Golaszewski, SM; Staffen, W; Ladurner, G
NEUROLOGY. 2010; 74(9): A416-A416.
Abstracts (Journal)
Short- and long-term decrease of soluble adhesion molecules (sICAM-1,-2,-3 and sVCAM-1) during natalizumab treatment
Oppermann, K; Pilz, G; Wipfler, P; Harrer, A; Sulzer, C; Afazel, S; Haschke-Becher, E; Ladurner, G; Kraus, J
J NEUROL. 2010; 257: S220-S220.
Abstracts (Journal)
Expression levels of cell surface bound interferon-receptor remain stable during short- and long-term interferon beta-1b treatment
Oppermann, K; Wipfler, P; Pilz, G; Harrer, A; Duerr, EM; Koczi, W; Sulzer, C; Afazel, S; Haschke-Becher, E; Ladurner, G; Kraus, J
J NEUROL. 2010; 257: S219-S219.
Abstracts (Journal)
Accumulation of natalizumab at the VLA-4 receptor as a potential molecular basis of enhanced treatment efficacy and occurrence of opportunistic infections
Wipfler, P; Oppermann, K; Pilz, G; Harrer, A; Haschke-Becher, E; Kunz, A; Golaszewski, S; Ladurner, G; Kraus, J
J NEUROL. 2010; 257: S8-S8.
Abstracts (Journal)
2009
Journal Articles
Clinical decision rules for the use of liquor diagnostics in hospitalized neurology patients reduced costs without affecting clinical outcomes.
Haschke-Becher, E; Totzke, U; Afazel, S; Johansson, T; Schwarz, M; Ladurner, G; Wild, C;
INT J TECHNOL ASSESS. 2009; 25(2): 208-213.
Full papers/articles (Journal)
Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations.
Stanger, O; Fowler, B; Piertzik, K; Huemer, M; Haschke-Becher, E; Semmler, A; Lorenzl, S; Linnebank, M;
Expert Rev Neurother. 2009; 9(9): 1393-1412.
Reviews
Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design.
van Schie, RM; Wadelius, MI; Kamali, F; Daly, AK; Manolopoulos, VG; de Boer, A; Barallon, R; Verhoef, TI; Kirchheiner, J; Haschke-Becher, E; Briz, M; Rosendaal, FR; Redekop, WK; Pirmohamed, M; Maitland van der Zee, AH;
PHARMACOGENOMICS. 2009; 10(10): 1687-1695.
Full papers/articles (Journal)
Conference papers, proceedings, abstracts
Short-term decrease of soluble adhesion molecules during natalizumab treatment
Oppermann, K; Pilz, G; Wipfler, P; Sulzer, C; Afazel, S; Haschke-Becher, E; Kunz, A; Golaszewski, S; Ladurner, G; Kraus, J
MULT SCLER. 2009; 15(9): S133-S133.
Abstracts (Journal)
Natalizumab Treatment Leads to Changes in Adhesion Molecule Expression
Wipfler, P; Pilz, G; Oppermann, K; Afazel, S; Haschke-Becher, E; Huemer, M; Jakab, M; Ritter, M; Ladurner, G; Kraus, J
NEUROLOGY. 2009; 72(11): A37-A38.
Abstracts (Journal)
Long-term effect of natalizumab on cell surface bound adhesion molecules expression
Wipfler, P; Pilz, G; Oppermann, K; Afazel, S; Huemer, M; Haschke-Becher, E; Staffen, W; Ladurner, G; Kraus, J
MULT SCLER. 2009; 15(9): S195-S196.
Abstracts (Journal)
2008
Journal Articles
Supplementation with 200 mg/day docosahexaenoic acid from mid-pregnancy through lactation improves the docosahexaenoic acid status of mothers with a habitually low fish intake and of their infants.
Bergmann, RL; Haschke-Becher, E; Klassen-Wigger, P; Bergmann, KE; Richter, R; Dudenhausen, JW; Grathwohl, D; Haschke, F;
ANN NUTR METAB. 2008; 52(2): 157-166.
Full papers/articles (Journal)
Urinary D-Lactate Excretion in Infants Receiving Lactobacillus johnsonii with Formula
Haschke-Becher, E; Brunser, O; Cruchet, S; Gotteland, M; Haschke, F; Bachmann, C
ANN NUTR METAB. 2008; 53(3-4): 240-244.
Full papers/articles (Journal)
A new high-throughput screening method for the detection of chronic lymphatic leukemia and myelodysplastic syndrome.
Haschke-Becher, E; Vockenhuber, M; Niedetzky, P; Totzke, U; Gabriel, C;
CLIN CHEM LAB MED. 2008; 46(1): 85-88.
Full papers/articles (Journal)
Intraplatform reproducibility and technical precision of gene expression profiling in 4 laboratories investigating 160 leukemia samples: the DACH study.
Kohlmann, A; Haschke-Becher, E; Wimmer, B; Huber-Wechselberger, A; Meyer-Monard, S; Huxol, H; Siegler, U; Rossier, M; Matthes, T; Rebsamen, M; Chiappe, A; Diemand, A; Rauhut, S; Johnson, A; Liu, WM; Williams, PM; Wieczorek, L; Haferlach, T;
CLIN CHEM. 2008; 54(10): 1705-1715.
Full papers/articles (Journal)
Safety and efficacy of a new extensively hydrolyzed formula for infants with cow"s milk protein allergy.
Niggemann, B; von Berg, A; Bollrath, C; Berdel, D; Schauer, U; Rieger, C; Haschke-Becher, E; Wahn, U;
Pediatr Allergy Immunol. 2008; 19(4):348-354
Full papers/articles (Journal)
Growth and metabolism of infants born to women infected with human immunodeficiency virus and fed acidified whey-adapted starter formulas.
Velaphi, SC; Cooper, PA; Bolton, KD; Mokhachane, M; Mphahlele, RM; Beckh-Arnold, E; Monaheng, L; Haschke-Becher, E;
Nutrition. 2008; 24(3):203-211
Full papers/articles (Journal)
Conference papers, proceedings, abstracts
Changes in adhesion molecule expression induced by natalizumab treatment in multiple sclerosis
Kraus, J; Pilz, G; Wipfler, P; Afazel, S; Haschke-Becher, E; Huemer, M; Jakab, M; Ritter, M; Ladurner, G
MULT SCLER. 2008; 14: S133-S133.
Abstracts (Journal)
Influence of natalizumab treatment on a panel of cell surface bound adhesion molecules
Wipfler, P; Pilz, G; Afazel, S; Haschke-Becher, E; Huemer, M; Jakab, M; Ritter, M; Ladurner, G; Kraus, J
J NEUROL. 2008; 255: 211-211.
Abstracts (Journal)
Newspaper/magazine articles
Einfluss einer Therapie der Multiplen Sklerose mit Natalizumab auf die Expression von zellgebundenen Adhäsionsmolekülen
Kraus, J; Wipfler, P; Pilz, G; Afazel, S; Haschke-Becher, E; Huemer, M; Jakab, M; Ritter, M; Ladurner, G
Akt Neurol. 2008. 35 - P584:
2007
Journal Articles
Does maternal docosahexaenoic acid supplementation during pregnancy and lactation lower BMI in late infancy?
Bergmann, RL; Bergmann, KE; Haschke-Becher, E; Richter, R; Dudenhausen, JW; Barclay, D; Haschke, F
J PERINAT MED. 2007; 35(4): 295-300.
Full papers/articles (Journal)
2006
Journal Articles
Effects of probiotic or prebiotic supplemented milk formulas on fecal microbiota composition of infants.
Brunser, O; Figueroa, G; Gotteland, M; Haschke-Becher, E; Magliola, C; Rochat, F; Cruchet, S; Palframan, R; Gibson, G; Chauffard, F; Haschke, F;
Asia Pac J Clin Nutr. 2006; 15(3):368-376
Full papers/articles (Journal)
2002
Journal Articles
Whey predominant, whey modified infant formula with protein/energy ratio of 1.8 g/100 kcal: adequate and safe for term infants from birth to four months.
Räihä, NC; Fazzolari-Nesci, A; Cajozzo, C; Puccio, G; Monestier, A; Moro, G; Minoli, I; Haschke-Becher, E; Bachmann, C; Van"t Hof, M; Carrié Fässler, AL; Haschke, F;
J Pediatr Gastroenterol Nutr. 2002; 35(3): 275-281.
Full papers/articles (Journal)
2000
Journal Articles
Assay of D-lactate in urine of infants and children with reference values taking into account data below detection limit.
Haschke-Becher, E; Baumgartner, M; Bachmann, C;
Clin Chim Acta. 2000; 298(1-2): 99-109.
Full papers/articles (Journal)
1994
Journal Articles
"Salt-split" test on normal, non-sun-exposed skin of patients with autoimmune subepidermal bullous diseases.
Pohla-Gubo, G; Becher, E; Romani, N; Fritsch, P; Hintner, H;
Dermatology. 1994; 189 Suppl 1: 123
Full papers/articles (Journal)